Arkolith/Insider Trading/MNPR/Form 4

Robinson Chandler

Chief Executive Officer, DirectorMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Jul 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$672K
Net Open-Market Flow
-$672K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2025Option exercise(X)17K$0.01$16890K
Jul 14, 2025Sell(S)17K$40.00$672K73K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 14, 2025Option exercise(X)17K—$00

Transaction Codes

X
Exercise of in-the-money derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-022861) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML